Covid-19 and its Ripple Effect on Clinical Trials

Our team came together to write an article on Covid-19 and its ripple effect on clinical trials for the Journal for Clinical Studies. Sofie Vandevyver, Daniel Tanner and Mario Papillon discussed the challenges Covid-19 revealed in clinical trials, the overwhelming amount of different assays for the detection of Covid-19 and which ones to use in clinical studies, and what the future of clinical trials might look like.

Download the article using the button below, or read a copy on the Journal for Clinical Studies’ website (https://issuu.com/mark123/docs/2020-jcs-3-june-web_compressed/22).

To find out more about our news, click here

Download

Back to Resources